With continued demand for face masks globally, Berry has been working closely with customers to help ensure production and supply. The investment will bring more than 400 metric tons of Meltex meltblown nonwoven material to the region, which will enable production of more than 500 million surgical-grade masks per year.
The new asset will be operational in the March 2021 quarter, will be placed at an existing Berry production facility in South America, and will focus on the production of materials for ASTM L2, L3, and N95 masks. The new line will be upgraded with Berry’s patented charging technology post installation.
“We are pleased to present this state-of-the-art meltblown capacity to the South American market. As customers prepare for future outbreaks or protection demands, we will be ready to serve,” says Daniel Guerrero, EVP & GM for Latin America in Health, Hygiene, and Specialties at Berry.